Taurine-based regenerative therapy for greatly improving Glaucoma: Taurine/2-Aminoethane-1-sulfonic acid increases the expression of genes that promote regeneration,  promotes reprogramming of aged eye cells, increases telomerase expression, increases Nicotinamide mononucleotide adenylyltransferase 1, which increases NAD+ levels, improves neuronal dysfunction, and protects against and reverses glaucoma, via up regulation of its target gene.